NASDAQ:AKTSAkoustis Technologies Stock Price, Forecast & News

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AKTS shares have increased by 47.5% and is now trading at $7.83. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Akoustis Technologies.

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Akoustis Technologies.

Akoustis Technologies Inc (NASDAQ:AKTS) announced its quarterly earnings data on Monday, May, 4th. The technology company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.01. The technology company earned $0.36 million during the quarter, compared to analysts' expectations of $0.51 million. Akoustis Technologies had a negative net margin of 1,595.99% and a negative return on equity of 87.59%. View Akoustis Technologies' earnings history.

3 Wall Street analysts have issued 12-month target prices for Akoustis Technologies' stock. Their forecasts range from $7.00 to $11.00. On average, they anticipate Akoustis Technologies' stock price to reach $9.33 in the next year. This suggests a possible upside of 19.2% from the stock's current price. View analysts' price targets for Akoustis Technologies.

Media coverage about AKTS stock has been trending negative on Saturday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Akoustis Technologies earned a news impact score of -2.7 on InfoTrie's scale. They also assigned news stories about the technology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news aboutAkoustis Technologies.

Some companies that are related to Akoustis Technologies include AudioCodes (AUDC), Infinera (INFN), NetGear (NTGR), ADTRAN (ADTN), Plantronics (PLT), Telkom SA Ltd ADS (TLKGY), DASAN Zhone Solutions (DZSI), Clearfield (CLFD), Franklin Wireless (FKWL), Communications Systems (JCS), Zoom Telephonics (ZMTP), Clearone (CLRO), AltiGen Communications (ATGN), Sonim Technologies (SONM) and Westell Technologies (WSTL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include NVIDIA (NVDA), Inseego (INSG), Alibaba Group (BABA), Editas Medicine (EDIT), Crispr Therapeutics (CRSP), Square (SQ), InVitae (NVTA), Marvell Technology Group (MRVL), Advanced Micro Devices (AMD) and QUALCOMM (QCOM).

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Akoustis Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.06%), Needham Investment Management LLC (1.65%), North Run Capital LP (1.36%), Geode Capital Management LLC (1.31%), State Street Corp (1.26%) and Taylor Frigon Capital Management LLC (0.99%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, John T Kurtzweil, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy. View institutional ownership trends for Akoustis Technologies.

AKTS stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Morgan Stanley, First Washington CORP, North Run Capital LP, Mission Wealth Management LP, Mission Wealth Management LP, Mutual of America Capital Management LLC, and UBS Group AG. Company insiders that have sold Akoustis Technologies company stock in the last year include David Aichele, Jeffrey B Shealy, Rohan Houlden, and Steven Denbaars. View insider buying and selling activity for Akoustis Technologies.

AKTS stock was bought by a variety of institutional investors in the last quarter, including Needham Investment Management LLC, Handelsinvest Investeringsforvaltning, Taylor Frigon Capital Management LLC, Geode Capital Management LLC, Taylor Frigon Capital Management LLC, BlackRock Inc., Granahan Investment Management Inc. MA, and Commonwealth Equity Services LLC. View insider buying and selling activity for Akoustis Technologies.

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AKTS stock can currently be purchased for approximately $7.83.

Akoustis Technologies has a market capitalization of $285.56 million and generates $1.44 million in revenue each year. Akoustis Technologies employs 69 workers across the globe.

The official website for Akoustis Technologies is www.akoustis.com.

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]